C-475HUntil Labs
reversible cryopreservation, vitrification, organ preservation
preservationcryonicsdevice hardware
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-475H
C-475HC-475Hreversible cryopreservation, vitrification, organ preservation
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Until Labs reversible cryopreservation, vitrification, organ preservation
Until Labs is developing reversible cryopreservation systems for human organs to address donor organ procurement and matching. Its work translates cryobiology into engineered workflows spanning perfusion, cryoprotectants, cooling, rewarming, and assessment of organ health. The company states that this organ-preservation work also de-risks questions relevant to whole-body reversible cryopreservation.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Until Labs — Early mechanism · Bottom quartile. Derived deterministically from 6 extracted project(s). Most-advanced status: preclinical. Band: early_mechanism. Modifiers: +5 depth (4 programs at preclinical).…
Source: Deterministic